Get startedLog in
    Picture of Shengtai Pharmaceutical logo

    SGTI — Shengtai Pharmaceutical Income Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Shengtai Pharmaceutical, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

    2012
    June 30th
    Period Length:12 M
    Source:10-K
    Standards:
    USG
    Status:Final
    Revenue
    Total Revenue179
    Cost of Revenue
    Gross Profit17.3
    Selling / General / Administrative Expenses
    Total Operating Expenses174
    Operating Profit5.5
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes1.07
    Provision for Income Taxes
    Net Income After Taxes1.07
    Net Income Before Extraordinary Items
    Net Income1.07
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income1.07
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS0.112
    Dividends per Share